OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Narrative review on clinical considerations for patients with diabetes and COVID‐19: More questions than answers
Niki Katsiki, Ricardo Gómez‐Huelgas, Dimitri P. Mikhailidis, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 11
Open Access | Times Cited: 13
Niki Katsiki, Ricardo Gómez‐Huelgas, Dimitri P. Mikhailidis, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 11
Open Access | Times Cited: 13
Showing 13 citing articles:
Noninsulin‐based antihyperglycemic medications in patients with diabetes and COVID ‐19: A systematic review and meta‐analysis
Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 86-96
Open Access | Times Cited: 13
Mahmoud Nassar, Hazem Abosheaishaa, Awadhesh Kumar Singh, et al.
Journal of Diabetes (2023) Vol. 15, Iss. 2, pp. 86-96
Open Access | Times Cited: 13
The role of nutrition on the treatment of Covid 19
Samer Younes
Human Nutrition & Metabolism (2024) Vol. 36, pp. 200255-200255
Open Access | Times Cited: 5
Samer Younes
Human Nutrition & Metabolism (2024) Vol. 36, pp. 200255-200255
Open Access | Times Cited: 5
Association of anti-diabetic drugs and COVID-19 outcomes in patients with diabetes mellitus type 2 and cardiomyopathy
Jelena Dimnjaković, Tamara Buble, Pero Ivanko, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
Jelena Dimnjaković, Tamara Buble, Pero Ivanko, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 3
New-Onset Diabetes Mellitus in COVID-19: A Scoping Review
Anca Pantea Stoian, Cristina Bică, Teodor Salmen, et al.
Diabetes Therapy (2023) Vol. 15, Iss. 1, pp. 33-60
Open Access | Times Cited: 9
Anca Pantea Stoian, Cristina Bică, Teodor Salmen, et al.
Diabetes Therapy (2023) Vol. 15, Iss. 1, pp. 33-60
Open Access | Times Cited: 9
COVID-19 and Inflammatory Markers
Şevket Balta, İlknur Balta
Current Vascular Pharmacology (2022) Vol. 20, Iss. 4, pp. 326-332
Closed Access | Times Cited: 12
Şevket Balta, İlknur Balta
Current Vascular Pharmacology (2022) Vol. 20, Iss. 4, pp. 326-332
Closed Access | Times Cited: 12
Impact of the COVID ‐19 pandemic on new diagnoses of type 2 diabetes in England
Emma Barron, Kamlesh Khunti, Alison K. Wright, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 11, pp. 3424-3429
Open Access | Times Cited: 3
Emma Barron, Kamlesh Khunti, Alison K. Wright, et al.
Diabetes Obesity and Metabolism (2023) Vol. 25, Iss. 11, pp. 3424-3429
Open Access | Times Cited: 3
The many facets of CD26/dipeptidyl peptidase 4 and its inhibitors in disorders of the CNS – a critical overview
Hans‐Gert Bernstein, Gerburg Keilhoff, Henrik Dobrowolny, et al.
Reviews in the Neurosciences (2022) Vol. 34, Iss. 1, pp. 1-24
Closed Access | Times Cited: 5
Hans‐Gert Bernstein, Gerburg Keilhoff, Henrik Dobrowolny, et al.
Reviews in the Neurosciences (2022) Vol. 34, Iss. 1, pp. 1-24
Closed Access | Times Cited: 5
SGLT2 Inhibitors in Long COVID Syndrome: Is There a Potential Role?
Paul Zimmermann, Harald Sourij, Felix Aberer, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 12, pp. 478-478
Open Access | Times Cited: 2
Paul Zimmermann, Harald Sourij, Felix Aberer, et al.
Journal of Cardiovascular Development and Disease (2023) Vol. 10, Iss. 12, pp. 478-478
Open Access | Times Cited: 2
Usefulness of the C2HEST Score in Predicting the Clinical Outcomes of COVID-19 in Diabetic and Non-Diabetic Cohorts
Damian Gajecki, Adrian Doroszko, Małgorzata Trocha, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 873-873
Open Access | Times Cited: 4
Damian Gajecki, Adrian Doroszko, Małgorzata Trocha, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 3, pp. 873-873
Open Access | Times Cited: 4
Effects of nutrients on immunomodulation in patients with severe COVID-19: Current knowledge
Bruna Teixeira da Costa, Glauber Rocha Lima Araújo, Ronaldo Teixeira da Silva Júnior, et al.
World Journal of Critical Care Medicine (2022) Vol. 11, Iss. 4, pp. 201-218
Open Access | Times Cited: 4
Bruna Teixeira da Costa, Glauber Rocha Lima Araújo, Ronaldo Teixeira da Silva Júnior, et al.
World Journal of Critical Care Medicine (2022) Vol. 11, Iss. 4, pp. 201-218
Open Access | Times Cited: 4
Análisis Real World Data de algunas repercusiones de la pandemia de COVID-19 sobre el control metabólico de las personas con DM2
Josep Franch‐Nadal
Diabetes práctica (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Josep Franch‐Nadal
Diabetes práctica (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Antidiabetic Drugs in COVID-19
Niki Katsiki, Maciej Banach
Contemporary cardiology (2022), pp. 351-364
Closed Access
Niki Katsiki, Maciej Banach
Contemporary cardiology (2022), pp. 351-364
Closed Access
